KLRB1 and acute lymphoblastic leukemia: Elevated LLT1 expression on T cells in high-risk ALL patients may contribute to the inhibitory LLT1–NKRP1A interaction with NK cells, potentially enabling leukemic cells to evade NK cell-mediated cytotoxicity.